Chapter 1 First cohort of FSHD and control plasma samples identifies complement components elevated in FSHD plasma

The first cohort consists of 24 FSHD and 12 control plasma samples. In this chapter, we compared the protein levels of complement components in FSHDs and controls from the first cohort. The tested complement components included six components of the classical/lectin activation pathway (C1q, C4, MBL, C4a, C2, C4b), four of the alternative pathway (Factor H, Factor I, Factor D, Factor B), and four of the terminal effector pathway (C3, C5, C5a, sC5b-9).

1.2 Statistics testing

The \(t\)-test comparing FSHDs and controls rendered three components, sC5b-9, C3, and C2, showing increased levels in FSHD. The code chunks below perform

  • \(t\)-testing comparing the complement components in FSHD and control groups
  • barplot of p-values (Figure 1.1; Fig. 2a) and complement levels distribution in each group (Figure 1.2; Fig. 2b)
  • heatmap and hierarchical cluster analysis (Figure 1.3; Suppl. Fig. S1)

1.2.1 t-tests

Cohort1 per-compoment t-tests: FSHD vs. controls. Annotation refers to p-values. * negative -10Log10(p-value) indicates negative t-statistics.

Figure 1.1: Cohort1 per-compoment t-tests: FSHD vs. controls. Annotation refers to p-values. * negative -10Log10(p-value) indicates negative t-statistics.